Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“There isn’t necessarily a pressure to innovate unless doctors listen to patients.”
Drug prevents mental decline associated with radiation therapy in mice.
New study finds that simple cysts should be considered normal and ignored.
Scientists are preparing to bring DNA-editing tools to the clinic.
Mutation revelation is a boon in an era of targeted therapies, say oncologists at UCSF, Children’s National Health System.
Human papillomavirus can cause anal, cervical, oral and other cancers.
Innovative model to drive understanding of the immune system in health and disease.
Novel technique lets researchers control common cancer pathway in the lab with pulses of light.
New target identified in glioblastoma could be effective against a common immortality mechanism in one third of cancers.
Clinical trial tests personalized treatments in push to improve pediatric cancer survival.
Research on severe inherited childhood skin disorder reveals how tissue injury can lead to cancer.
Efficacy of novel approach in human lung, skin, colon, pancreatic cancers in lab experiments prompts rapid move toward clinical trial.
The study focused on children with a form of acute myeloid leukemia (AML), and the findings could also be relevant to other blood disorders.
The researchers hope to soon increase the scale of their gene mapping to focus on diseases such as lung cancer and prostate cancer.
Whole-genome analysis of aggressive disease offers insights into possible personalized therapies
Innovative CRISPR study recreates genetic steps required for benign moles to turn malignant
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.